IAVI Trials Database - IAVI - International AIDS Vaccine Initiative

VRC 016

VRC 016 A Phase 1b Open-Label, Randomized Clinical Trial to Evaluate Early Innate and Adaptive Immune Responses to the Investigational HIV-1 Vaccines: VRC-HIVADV014-00-VP and VRC-HIVDNA016-00-VP in Ad5 Seronegative Healthy Adults

Trial Details:

Phase:	Ib	Status:	Completed
Organizer developer:	National Institute of Allergy and Infectious Diseases (NIAID)	Start Date:	June 01, 2011
Product:	VRC-HIVADV014-00-VP,VRC-HIVDNA016-00-VP	Antigen:	DNA env A, env b, env C, gag B, pol B, nef B; Ad5 env A, env B, env C, gag B, pol B
Prime 1:	VRC-HIVDNA016-00-VP	Prime Class:	DNA
Boost 1:	VRC-HIVADV014-00-VP	Boost 1 class:	Viral Vector - Adeno
Boost 2:		Boost 2 Class:
Boost 3:		Boost 3 Class:
Adjuvant:
Country:	USA	Volunteers:	36
ClinicalTrials.gov Identifier:
Link: http://clinicaltrials.gov/ct2/show/NCT01386489?term=hiv+vaccine&lup_s=06%2F25%2F2011&lup_d=30